Effect of remimazolam vs propofol in high-risk patients undergoing upper gastrointestinal endoscopy: a non-inferiority randomized controlled trial
Abstract Background Procedural sedation is essential for optimizing upper gastrointestinal endoscopy, particularly in high-risk patients with multiple underlying diseases. Respiratory and circulatory complications present significant challenges for procedural sedation in this population. This non-in...
Main Authors: | Zhi Li, Daming Yuan, Yu Yu, Jie Xu, Weili Yang, Li Chen, Nanbo Luo |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-01-01
|
Series: | Trials |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13063-024-07934-z |
Similar Items
-
Efficacy and Safety of Different Doses of Remimazolam Tosilate Applied in Upper Gastrointestinal Endoscopy: A Prospective Randomized Controlled Double-Blind Trial
by: Cui X, et al.
Published: (2023-09-01) -
Efficacy and safety of remimazolam tosylate for sedation during upper gastrointestinal endoscopy: study protocol for a multicenter randomized controlled trial
by: Huichen Zhu, et al.
Published: (2022-12-01) -
Comparison of Remimazolam and Propofol in Recovery of Elderly Outpatients Undergoing Gastrointestinal Endoscopy: A Randomized, Non-Inferiority Trial
by: Lu L, et al.
Published: (2024-09-01) -
Remimazolam tosilate compared with propofol for gastrointestinal endoscopy in elderly patients: a prospective, randomized and controlled study
by: Jian Guo, et al.
Published: (2022-06-01) -
The use of remimazolam in gastrointestinal endoscopy for obese patients
by: Xueqian Leng, et al.
Published: (2025-01-01)